Logo

University of Michigan Wins $6M NIAID Grant to Help Develop Anthrax Vaccine

Dec 02, 2004

NEW YORK, Dec. 2 (GenomeWeb News) - The University of Michigan Medical School has won a $5.9 million grant from the National Institute of Allergy and Infectious Diseases to apply its proteomics research to help develop a widely used anthrax vaccine, the school said today.

 

Michiganwas chosen as one of seven government-funded Biodefense Proteomics Research Centers. Philip Hanna is co-director of the center and assistant professor of microbiology and immunology at the university.

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.